Jason Brunton and Kali Iyer Honored for Innovation, Leadership, and Measurable Impact in the Consulting Industry
Philadelphia, PA – April 5, 2025 – Herspiegel, a world leader in pharmaceutical and biotech commercialization services, is proud to announce that Jason Brunton, Principal of Insights and Analytics, and Kali Iyer, Senior Manager of Science and Strategy, have been recognized in Consulting Magazine’s 2025 Rising Stars of the Profession Awards in the Excellence in Strategy Consulting category for their innovative contributions and measurable impact.
The Rising Stars of the Profession awards honor consultants who have demonstrated extraordinary leadership and impact within the healthcare sector. This year, Jason and Kali were recognized for their impactful contributions to shaping business practices and advancing client success through innovative, strategic solutions in the pharmaceutical industry.
Jason Brunton has been recognized for bridging the gap between clinical and commercial organizational functions, specifically in immunology and rare disease franchises. He leverages his scientific background, constant drive to expand his market knowledge, and unique operational approaches to generate the breadth and quality of insights needed to build and refine these strategies. Jason applies these approaches to drive better decision-making in rare or complex specialty markets with limited visibility. Jason holds a BS from Michigan State University and a PhD in Microbiology and Immunology from the University of North Carolina Chapel Hill.
Kali Iyer has been recognized for supporting Medical Affairs and Patient Advocacy teams in strategic planning and insight generation through stakeholder engagement. She has extensive experience working with HCPs, patients, caregivers, and advocate stakeholders across various therapeutic areas to infuse their insights into informed decision-making. Kali has expertise in integrating the patient voice into strategic planning, resource generation, cross-functional decisions, and regulatory discussions. With a PhD in Molecular Genetics from the University of Toronto and a background in infectious disease research, she brings scientific rigor to clear, effective communication.
Herspiegel congratulates Jason and Kali for their recognition and looks forward to their continued success in shaping the future of healthcare consulting.
ABOUT HERSPIEGEL
Herspiegel is a leading commercialization consulting firm helping life science clients maximize brand potential. With expertise across market access, medical affairs, marketing, and patient services, Herspiegel has supported over 150 pharmaceutical product launches spanning oncology, rare disease, biosimilars, and generalized medicine brands. Our team of MDs, PhDs, MBAs, and pharmacists deliver actionable strategies that achieve measurable long-term success for our clients.
